Phone: 203-431-3905
Website: http://www.OpStat.com

Contact(s)
Jim Curry - JimCurry@OpStat.com

General Information
With biopharma experience since 1987, OpStat’s innovative simulation and optimization models for clinical, supply chain, quality and financial management are the state of the art in strategic and tactical planning for a portfolio of products in development.

OpStat’s Strategic Capacity Model uses Monte Carlo simulation technology to develop how much capacity is required, and where products should be manufactured. It computes the optimum profit based on probabilistic forecasts, tax structures, royalties, operating costs and contractual commitments.

The Clinical Supply Model incorporates study arms, pack types and visit schedules with the projected and actual recruitment to simulate dispensation from clinical sites back through the supply chain. It projects site inventory and supply flow during clinical trials, simulating the impact of timing and scale of operation on resource utilization, product yield and drug substance usage.

The Lean Manufacturing and Laboratory Models simulate the supply chain from cell fermentation, formulation, filling, to packaging. The simulations model all forms of product manufacturing – liquids, solids, lyophilized, parenterals, biologicals, vials, syringes, specialized delivery. Comprehensive laboratory test profiles are incorporated to accurately predict equipment and staff required to fit the predicted mix of test requests, as well as staff training levels and shift schedules.

Other Information
Ownership: Private
CT Employees: 3
World Employees: 10

Back